Study to Gather Information About the Use of Healthcare Services and the Way the Disease is Cared for in Canadian Patients With Prostate Gland Cancer Which Spread Throughout the Body

CompletedOBSERVATIONAL
Enrollment

4,301

Participants

Timeline

Start Date

February 24, 2020

Primary Completion Date

June 22, 2021

Study Completion Date

June 22, 2021

Conditions
Prostate Cancer
Interventions
DRUG

Radium-223 dichloride (Xofigo, BAY88-8223)

Follow clinical administration

Trial Locations (1)

Unknown

Multiple Locations, Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY